Translational Development Acquisition Corp. (TDAC) Financial Statements
Translational Development Acquisition Corp. Financial Overview
Translational Development Acquisition Corp.'s market cap is currently $208.92M. The company's EPS TTM is $0.26; its P/E ratio is 42.00; Translational Development Acquisition Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -944.54K | $ -196.36K | $ -485.55K | $ -70.66K | $ -1.39M |
| EBITDA | $ -944.54K | $ -196.36K | $ -485.55K | $ 0.00 | $ -1.03M |
| Net Income | $ 6.36M | $ -71.01K | $ -485.55K | $ -70.66K | $ -809.05K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 29.79K | $ 438.17K | $ 2.02K | $ 2.23K | $ 64.38M |
| Total Assets | $ 181.70M | $ 175.00M | $ 2.02K | $ 437.24K | $ 64.66M |
| Total Debt | $ 200.00K | $ 0.00 | $ 347.50K | $ 259.00K | $ 5.08M |
| Net Debt | $ 170.21K | $ -438.17K | $ 345.48K | $ 256.77K | $ 4.10M |
| Total Liabilities | $ 6.58M | $ 6.25M | $ 509.68K | $ 459.34K | $ 10.43M |
| Stockholders' Equity | $ 175.12M | $ 168.75M | $ -507.66K | $ -22.11K | $ 54.23M |
| Cash Flow | |||||
| Free Cash Flow | $ -608.39K | $ -851.45K | $ -204.00 | $ -97.16K | $ -1.85M |
| Operating Cash Flow | $ -608.39K | $ -851.45K | $ -204.00 | $ -97.16K | $ -1.85M |
| Investing Cash Flow | $ 0.00 | $ -174.22M | $ 0.00 | $ 0.00 | $ 11.32M |
| Financing Cash Flow | $ 200.00K | $ 175.51M | $ 0.00 | $ 99.39K | $ -8.55M |
Currency in USD
